First test to detect recently discovered autoimmune disease associated with testicular cancer

Mayo Clinic Laboratories has launched a first-of-its-kind test to detect an autoimmune disease called

testicular cancer-associated paraneoplastic encephalitis. The test, available nationally and internationally, detects the Kelch-like protein 11 antibody, or KLHL11, and is a result of the breakthrough study from 2019 that discovered the disease. This test has already provided patients, such as Steven Wopperer of Temecula, California, a diagnosis after he struggled for three years to find an answer to his vision and balance problems.

Read full news release on the Mayo Clinic Laboratories’ website.


/Public Release, Courtesy: Mayo Clinic. This material comes from the originating organization/author(s)and may be of a point-in-time nature, edited for clarity, style and length. The views and opinions expressed are those of the author(s).View in full here.